Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00352482
What this trial is testing

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
National Heart, Lung, and Blood Institute (NHLBI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Post-approval studies (Phase 4)Study completedNCT02143687
What this trial is testing

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance

Who this might be right for
Precapillary Pulmonary HypertensionInterstitial Lung Disease
University of Zurich 30
Not applicableEnrolling By InvitationNCT04930289
What this trial is testing

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Who this might be right for
Interstitial Lung DiseaseCOPDCystic Fibrosis+3 more
Paragonix Technologies 3,500
Large-scale testing (Phase 3)Study completedNCT05649722
What this trial is testing

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 31
Not applicableActive Not RecruitingNCT05867914
What this trial is testing

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

Who this might be right for
Hypertension, PulmonaryLung Diseases, Interstitial
Third Pole Therapeutics, Inc. 5
Post-approval studies (Phase 4)UnknownNCT02150616
What this trial is testing

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep

Who this might be right for
Precapillary Pulmonary HypertensionInterstitial Lung Disease
University of Zurich 50
Not applicableLooking for participantsNCT06129240
What this trial is testing

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Liquidia Technologies, Inc. 80
Large-scale testing (Phase 3)Looking for participantsNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Not applicableStudy completedNCT03718780
What this trial is testing

Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise

Who this might be right for
Pulmonary Disease, Chronic ObstructiveLung Diseases, InterstitialChronic Heart Failure+3 more
Centre Hospitalier Metropole Savoie 140
Not applicableStudy completedNCT01443598
What this trial is testing

Pulmonary Hypertension in Interstitial Lung Disease

Who this might be right for
Pulmonary Arterial HypertensionDiffuse Interstitial Lung Disease
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 224
Not applicableStudy completedNCT03396120
What this trial is testing

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseasePulmonary Hypertension
Assiut University 95
Testing effectiveness (Phase 2)Looking for participantsNCT05798923
What this trial is testing

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
OrphAI Therapeutics 85
Not applicableLooking for participantsNCT06388421
What this trial is testing

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and HypoxiaPulmonary HypertensionInterstitial Lung Disease
United Therapeutics 900
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Post-approval studies (Phase 4)WithdrawnNCT00625469
What this trial is testing

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Rajan Saggar
Large-scale testing (Phase 3)Looking for participantsNCT07816185
What this trial is testing

Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseVascular Diseases+2 more
Pulmovant, Inc. 376
Testing effectiveness (Phase 2)Study completedNCT07542067
What this trial is testing

Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Fundación Neumologica Colombiana 1
Testing effectiveness (Phase 2)Looking for participantsNCT06038630
What this trial is testing

129Xe MRI Cardiopulmonary

Who this might be right for
Interstitial Lung DiseaseChronic Thromboembolic Pulmonary HypertensionAcute Pulmonary Embolism+3 more
Bastiaan Driehuys 125
Next Page